Where Do We Go From Here? Incorporating the HER2 Expression Continuum Into mBC Management

This initiative will empower clinicians with up-to-date knowledge on HER2-low and HER2-ultralow mBC, clarify testing interpretation challenges, and provide practical guidance on integrating therapies such as T-DXd into mBC care.